S&P 500   4,164.00
DOW   34,156.69
QQQ   309.88
Two Billionaires Are Rigging the Market. Here’s How to Fight Back
The #1 Energy Stock to Buy (Ad)
3 Hot Stocks The Analysts Are Buying 
Is Biotech Immunocore About To Make A 25% Price Move?
The #1 Energy Stock to Buy (Ad)
Why Is Wall Street Loving Amazon So Much? 
Want to Invest in ChatGPT? Then Buy Microsoft Stock
The #1 Energy Stock to Buy (Ad)
Stocks end higher after zig-zagging on Fed chair's comments
Patient Clorox Shareholders Are Cleaning Up
S&P 500   4,164.00
DOW   34,156.69
QQQ   309.88
Two Billionaires Are Rigging the Market. Here’s How to Fight Back
The #1 Energy Stock to Buy (Ad)
3 Hot Stocks The Analysts Are Buying 
Is Biotech Immunocore About To Make A 25% Price Move?
The #1 Energy Stock to Buy (Ad)
Why Is Wall Street Loving Amazon So Much? 
Want to Invest in ChatGPT? Then Buy Microsoft Stock
The #1 Energy Stock to Buy (Ad)
Stocks end higher after zig-zagging on Fed chair's comments
Patient Clorox Shareholders Are Cleaning Up
S&P 500   4,164.00
DOW   34,156.69
QQQ   309.88
Two Billionaires Are Rigging the Market. Here’s How to Fight Back
The #1 Energy Stock to Buy (Ad)
3 Hot Stocks The Analysts Are Buying 
Is Biotech Immunocore About To Make A 25% Price Move?
The #1 Energy Stock to Buy (Ad)
Why Is Wall Street Loving Amazon So Much? 
Want to Invest in ChatGPT? Then Buy Microsoft Stock
The #1 Energy Stock to Buy (Ad)
Stocks end higher after zig-zagging on Fed chair's comments
Patient Clorox Shareholders Are Cleaning Up
S&P 500   4,164.00
DOW   34,156.69
QQQ   309.88
Two Billionaires Are Rigging the Market. Here’s How to Fight Back
The #1 Energy Stock to Buy (Ad)
3 Hot Stocks The Analysts Are Buying 
Is Biotech Immunocore About To Make A 25% Price Move?
The #1 Energy Stock to Buy (Ad)
Why Is Wall Street Loving Amazon So Much? 
Want to Invest in ChatGPT? Then Buy Microsoft Stock
The #1 Energy Stock to Buy (Ad)
Stocks end higher after zig-zagging on Fed chair's comments
Patient Clorox Shareholders Are Cleaning Up
NYSE:TBI

TrueBlue - TBI Stock Forecast, Price & News

$18.64
+0.13 (+0.70%)
(As of 02/7/2023 12:00 AM ET)
Add
Compare
Today's Range
$18.30
$18.88
50-Day Range
$18.08
$21.58
52-Week Range
$15.77
$30.32
Volume
230,595 shs
Average Volume
151,996 shs
Market Capitalization
$609.90 million
P/E Ratio
10.02
Dividend Yield
N/A
Price Target
$20.50

TrueBlue MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
10.0% Upside
$20.50 Price Target
Short Interest
Healthy
1.66% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.57mentions of TrueBlue in the last 14 days
Based on 11 Articles This Week
Insider Trading
Selling Shares
$32,607 Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.87 out of 5 stars

Business Services Sector

129th out of 322 stocks

Help Supply Services Industry

14th out of 17 stocks

TBI stock logo

About TrueBlue (NYSE:TBI) Stock

TrueBlue, Inc. engages in the provision of staffing, recruitment process outsourcing and managed service provider solutions. It operates through the following segments: PeopleReady, PeopleManagement and PeopleScout. The PeopleReady segment offers staffing solutions for blue-collar, contingent on-demand and skilled labor to a broad range of industries that include retail, manufacturing, warehousing, logistics, energy, construction, hospitality and others. The PeopleManagement segment supplies contingent labor and outsourced industrial workforce solutions. The PeopleScout segment covers the provision of permanent employee recruitment process outsourcing for its customers for all major industries and jobs. The company was founded by John Ross Coghlan and Glenn Welstad in 1989 and is headquartered in Tacoma, WA.

Receive TBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TrueBlue and its competitors with MarketBeat's FREE daily newsletter.

TBI Stock News Headlines

TrueBlue Full Year 2022 Earnings: EPS Misses Expectations
The #1 Energy Stock to Buy
The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…
TrueBlue (NYSE:TBI) Downgraded by StockNews.com to "Hold"
TrueBlue (TBI) Set to Announce Quarterly Earnings on Wednesday
The #1 Energy Stock to Buy
The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…
Why TrueBlue, Inc. (NYSE:TBI) Could Be Worth Watching
TrueBlue, Inc. (TBI) Q3 2022 Earnings Call Transcript
TrueBlue Reports Third Quarter 2022 Results
See More Headlines
Receive TBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TrueBlue and its competitors with MarketBeat's FREE daily newsletter.

TBI Company Calendar

Last Earnings
2/01/2023
Today
2/07/2023
Next Earnings (Estimated)
4/24/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Help supply services
Sub-Industry
Human Resource & Employment Services
CUSIP
89785X10
Employees
6,400
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$20.50
High Stock Price Forecast
$21.00
Low Stock Price Forecast
$20.00
Forecasted Upside/Downside
+10.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$62.27 million
Pretax Margin
3.26%

Debt

Sales & Book Value

Annual Sales
$2.25 billion
Cash Flow
$3.36 per share
Book Value
$15.17 per share

Miscellaneous

Free Float
32,065,000
Market Cap
$609.90 million
Optionable
Optionable
Beta
1.44

Key Executives

  • Steven C. Cooper
    Chief Executive Officer & Director
  • Taryn R. OwenTaryn R. Owen
    President & Chief Operating Officer
  • Derrek L. GaffordDerrek L. Gafford
    Chief Financial Officer & Executive Vice President
  • Jeffrey S. Dirks
    Chief Information & Technology Officer
  • Garrett R. Ferencz
    Chief Legal Officer, General Counsel & EVP













TBI Stock - Frequently Asked Questions

Should I buy or sell TrueBlue stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for TrueBlue in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" TBI shares.
View TBI analyst ratings
or view top-rated stocks.

What is TrueBlue's stock price forecast for 2023?

2 brokerages have issued 1-year price objectives for TrueBlue's shares. Their TBI share price forecasts range from $20.00 to $21.00. On average, they anticipate the company's stock price to reach $20.50 in the next twelve months. This suggests a possible upside of 10.0% from the stock's current price.
View analysts price targets for TBI
or view top-rated stocks among Wall Street analysts.

How have TBI shares performed in 2023?

TrueBlue's stock was trading at $19.58 at the beginning of the year. Since then, TBI stock has decreased by 4.8% and is now trading at $18.64.
View the best growth stocks for 2023 here
.

When is TrueBlue's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, April 24th 2023.
View our TBI earnings forecast
.

How were TrueBlue's earnings last quarter?

TrueBlue, Inc. (NYSE:TBI) issued its quarterly earnings data on Wednesday, February, 1st. The business services provider reported $0.43 earnings per share for the quarter, topping analysts' consensus estimates of $0.41 by $0.02. The business services provider had revenue of $557.70 million for the quarter, compared to the consensus estimate of $562.93 million. TrueBlue had a trailing twelve-month return on equity of 16.95% and a net margin of 2.76%. The business's revenue for the quarter was down 10.3% compared to the same quarter last year. During the same quarter last year, the company posted $0.69 earnings per share.

What guidance has TrueBlue issued on next quarter's earnings?

TrueBlue issued an update on its first quarter 2023 earnings guidance on Wednesday, February, 1st. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $455.00 million-$480.00 million, compared to the consensus revenue estimate of $492.18 million.

What is Patrick Beharelle's approval rating as TrueBlue's CEO?

34 employees have rated TrueBlue Chief Executive Officer Patrick Beharelle on Glassdoor.com. Patrick Beharelle has an approval rating of 56% among the company's employees. This puts Patrick Beharelle in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of TrueBlue own?

Based on aggregate information from My MarketBeat watchlists, some companies that other TrueBlue investors own include International Business Machines (IBM), Intel (INTC), NVIDIA (NVDA), Vertex Pharmaceuticals (VRTX), Gilead Sciences (GILD), The Goldman Sachs Group (GS), AT&T (T), Zynga (ZNGA), AbbVie (ABBV) and Amgen (AMGN).

What is TrueBlue's stock symbol?

TrueBlue trades on the New York Stock Exchange (NYSE) under the ticker symbol "TBI."

Who are TrueBlue's major shareholders?

TrueBlue's stock is owned by a number of institutional and retail investors. Top institutional investors include Pzena Investment Management LLC (6.74%), Pacer Advisors Inc. (0.94%), New York State Teachers Retirement System (0.24%), New York State Common Retirement Fund (0.16%), AE Wealth Management LLC (0.15%) and SummerHaven Investment Management LLC (0.13%). Insiders that own company stock include A Patrick Beharelle, Carl Schweihs, Colleen B Brown, Derrek Lane Gafford, Garrett Ferencz, Richard Christensen, Steven C Cooper, Taryn R Owen and William C Goings.
View institutional ownership trends
.

How do I buy shares of TrueBlue?

Shares of TBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is TrueBlue's stock price today?

One share of TBI stock can currently be purchased for approximately $18.64.

How much money does TrueBlue make?

TrueBlue (NYSE:TBI) has a market capitalization of $609.90 million and generates $2.25 billion in revenue each year. The business services provider earns $62.27 million in net income (profit) each year or $1.86 on an earnings per share basis.

How many employees does TrueBlue have?

The company employs 6,400 workers across the globe.

How can I contact TrueBlue?

TrueBlue's mailing address is 1015 A STREET, TACOMA WA, 98402. The official website for the company is www.trueblue.com. The business services provider can be reached via phone at (253) 383-9101, via email at investorrelations@trueblueinc.com, or via fax at 877-733-0399.

This page (NYSE:TBI) was last updated on 2/8/2023 by MarketBeat.com Staff